GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹269 Cr | ₹320 Cr | ₹3.82 Cr | ₹3.93 Cr | ₹4.07 Cr |
What is the latest Total Debt ratio of GLAND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹3.82 Cr |
| Mar2022 | ₹3.93 Cr |
| Mar2021 | ₹4.07 Cr |
How is Total Debt of GLAND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | -15.81 | |
| Mar2024 | ₹320 Cr | 8,269.07 | |
| Mar2023 | ₹3.82 Cr | -2.85 | |
| Mar2022 | ₹3.93 Cr | -3.34 | |
| Mar2021 | ₹4.07 Cr | - | |
Compare Total Debt of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹26,511.4 Cr | -4.6% | -11.4% | -1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -4.6% |
-11.4% |
-1.7% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses